Malak Almutairi
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy.
Journal: The Canadian journal of cardiology
Published: July 30, 2019
The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity.
Journal: JCI insight
Published: August 31, 2018
Glucagon-like peptide-1 receptor action in the vasculature.
Journal: Peptides
Published: July 04, 2018
Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet.
Journal: Diabetologia
Published: February 16, 2018
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction.
Journal: Frontiers in cardiovascular medicine
Published: January 14, 2018
Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism.
Journal: Peptides
Published: October 15, 2017
Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development.
Journal: Canadian journal of physiology and pharmacology
Published: September 09, 2017
FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Journal: American journal of physiology. Heart and circulatory physiology
Published: March 29, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026